Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Merck revenue
Merck's revenue is $64.2 billion.
What is Merck's revenue?
- Merck's revenue growth from 1999 to 2024 is 603.91%.
- Merck has 74,000 employees, and the revenue per employee ratio is $867,135.
- Merck's peak quarterly revenue was $16.7B in 2024(q3).
- Merck peak revenue was $64.2B in 2024.
- Merck annual revenue for 2023 was 60.1B, 1.4% growth from 2022.
- Merck annual revenue for 2024 was 64.2B, 6.74% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Merck historical revenue
Merck's peak revenue was $64.2B in 2024. The peak quarterly revenue was $16.7B in 2024(q3).
Merck's revenue increased from $9.1b in 1999 to $64.2B currently. That's a 603.91% change in annual revenue.
Merck annual revenue
Merck annual revenue over time
| Fiscal year / year | Merck revenue |
|---|---|
| 2009 | $27.4B |
| 2010 | $46.0B |
| 2011 | $48.0B |
| 2012 | $47.3B |
| 2013 | $44.0B |
| 2014 | $42.2B |
| 2015 | $39.5B |
| 2016 | $39.8B |
| 2017 | $40.1B |
| 2018 | $42.3B |
| 2019 | $39.1B |
| 2020 | $41.5B |
| 2021 | $48.7B |
| 2022 | $59.3B |
| 2023 | $60.1B |
| 2024 | $64.2B |
Rate Merck's financial transparency
Merck annual growth
Merck saw the greatest revenue growth in 2007, when revenue increased by 128.41%.
Merck had the lowest revenue growth in 2003, when revenue changed by -18.13%.
Merck annual growth rate over time
| Year | Merck growth |
|---|---|
| 2009 | 15%↑ |
| 2010 | 68%↑ |
| 2011 | 4%↑ |
| 2012 | -2%↓ |
| 2013 | -7%↓ |
| 2014 | -4%↓ |
| 2015 | -6%↓ |
| 2016 | 1%↑ |
| 2017 | 1%↑ |
| 2018 | 5%↑ |
| 2019 | -8%↓ |
| 2020 | 6%↑ |
| 2021 | 17%↑ |
| 2022 | 22%↑ |
| 2023 | 1%↑ |
| 2024 | 7%↑ |
Merck quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Merck quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | - | - | $6.0B | $10.1B |
| 2010 | $11.4B | $11.3B | $11.1B | $12.1B |
| 2011 | $11.6B | $12.2B | $12.0B | $12.3B |
| 2012 | $11.7B | $12.3B | $11.5B | $11.7B |
| 2013 | $10.7B | $11.0B | $11.0B | $11.3B |
| 2014 | $10.3B | $10.9B | $10.6B | $10.5B |
| 2015 | $9.4B | $9.8B | $10.1B | $10.2B |
| 2016 | $9.3B | $9.8B | $10.5B | $10.1B |
| 2017 | $9.4B | $9.9B | $10.3B | $10.4B |
| 2018 | $10.0B | $10.5B | $10.8B | $11.0B |
| 2019 | $10.8B | $11.8B | $12.4B | $4.1B |
| 2020 | $12.1B | $9.4B | $10.9B | $10.9B |
| 2021 | $10.6B | $11.4B | $13.2B | $13.5B |
| 2022 | $15.9B | $14.6B | $15.0B | $13.8B |
| 2023 | $14.5B | $15.0B | $16.0B | $14.6B |
| 2024 | $15.8B | $16.1B | $16.7B | $15.6B |
Merck jobs nearby
Do you work at Merck?
Did Merck meet its revenue projections?
Merck financial information
| CEO | Robert M. Davis |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 74,000 |
| Date Founded | 1891 |
| Headquarters | Kenilworth, New Jersey |
| Number of Locations | 138 |
| Revenue | $64.2B |
| Net Income | $14,519,000,000 |
| Gross Proft | $49.0B (2024) |
| PE Ratio | 12.33 |
| Tax Rate | 0.1% |
| Market Capitalization | $211.0B |
| Total Assets | $109,160,000,000 |
| Ticker | MRK |
Merck jobs you might like
Merck financing
Merck received early financing of $5.0M on 2016-01-21.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $5M | 01/2016 |
| Post Ipo Equity | $586K | 11/2018 |
Merck investors
| Investors | Security type |
|---|---|
| Gavi | Series Unknown |
| Private Capital Advisors Inc | Post Ipo Equity |
Merck competitors
Merck's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.
Merck's smallest competitor is Sanofi US with revenue of $980.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Johnson & Johnson | $76,686 | $88.8B | 134,500 | 1,542 |
| Amgen | $93,349 | $33.4B | 22,000 | 564 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 560 |
| Bayer | $89,204 | $17.0B | 20,735 | 3,270 |
| Zoetis | $87,092 | $9.3B | 11,300 | 207 |
| Seagen | $85,008 | $2.0B | 900 | - |
| Sanofi Genzyme | $84,495 | $4.6B | 12,000 | - |
| Bristol-Myers Squibb | $101,824 | $48.3B | 30,000 | 947 |
| Pfizer | $70,868 | $63.6B | 78,500 | 369 |
| Eli Lilly and Company | $100,905 | $45.0B | 33,625 | 644 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Merck highest paying jobs
Zippia gives an in-depth look into the details of Merck, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Merck. The employee data is based on information from people who have self-reported their past or current employments at Merck. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Merck. The data presented on this page does not represent the view of Merck and its employees or that of Zippia.
Merck may also be known as or be related to Merck, Merck & Co Inc, Merck & Co., Merck & Co. Inc., Merck & Co., Inc., Merck Patient Assistance Program, Inc., Merck Sharp & Dohme Corp. and merck/schering-plough.